Bonacchi, G.; Rossi, V.A.; Garofalo, M.; Mollace, R.; Uccello, G.; Pieragnoli, P.; Checchi, L.; Perrotta, L.; Voltolini, L.; Ricciardi, G.;
et al. Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease. Biomedicines 2024, 12, 981.
https://doi.org/10.3390/biomedicines12050981
AMA Style
Bonacchi G, Rossi VA, Garofalo M, Mollace R, Uccello G, Pieragnoli P, Checchi L, Perrotta L, Voltolini L, Ricciardi G,
et al. Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease. Biomedicines. 2024; 12(5):981.
https://doi.org/10.3390/biomedicines12050981
Chicago/Turabian Style
Bonacchi, Giacomo, Valentina Alice Rossi, Manuel Garofalo, Rocco Mollace, Giuseppe Uccello, Paolo Pieragnoli, Luca Checchi, Laura Perrotta, Luca Voltolini, Giuseppe Ricciardi,
and et al. 2024. "Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease" Biomedicines 12, no. 5: 981.
https://doi.org/10.3390/biomedicines12050981
APA Style
Bonacchi, G., Rossi, V. A., Garofalo, M., Mollace, R., Uccello, G., Pieragnoli, P., Checchi, L., Perrotta, L., Voltolini, L., Ricciardi, G., & Beltrami, M.
(2024). Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease. Biomedicines, 12(5), 981.
https://doi.org/10.3390/biomedicines12050981
